Biotech Breakthroughs
Exciting advancements in biotechnology are reshaping the landscape of medicine, with over 250 new drugs approved in recent years. The introduction of gene therapies, particularly for conditions like hemophilia and muscular dystrophy, highlights the potential for transformative treatments. However, the investment landscape remains challenging, as 90% of therapies that enter clinical testing fail to reach the market, making it crucial for investors to identify the rare successes.In this clip
From this podcast
Capital Allocators – Inside the Institutional Investment Industry
[REPLAY] Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)
Related Questions